Abstract
Neurotransmitter assay of epinephrine (EP) was sought using a modified carbon nanotube paste electrode (PE). Using optimum conditions, cyclic voltammetry (CV) and the square wave (SW) stripping voltammetric working ranges were attained to 10-100 mgL-1 (CV) and 20-140 ngL-1 (SW). The relative standard deviation of 0.0549 (n=15) was obtained at 20.0 mgL-1 EP constant. Here, the analytical detection limit (S/N) was reached with 4.60 ngL-1 (2.5×10-11 molL-1) EP. The hand-made electrode was implanted into the in-vivo brain core of the animals and was used in chronoamperometric neuro detection. The results obtained are applicable in neuro sensing, physiological control, and other neuroscience fields.
Keywords: Epinephrine, neuro sens, electrochemical, brain, in vivo, interface.
Current Neurovascular Research
Title:Implementation of a Biocircuit Implants for Neurotransmitter Release During Neuro-Stimulation
Volume: 10 Issue: 3
Author(s): Suw Young Ly and Dal woong Choi
Affiliation:
Keywords: Epinephrine, neuro sens, electrochemical, brain, in vivo, interface.
Abstract: Neurotransmitter assay of epinephrine (EP) was sought using a modified carbon nanotube paste electrode (PE). Using optimum conditions, cyclic voltammetry (CV) and the square wave (SW) stripping voltammetric working ranges were attained to 10-100 mgL-1 (CV) and 20-140 ngL-1 (SW). The relative standard deviation of 0.0549 (n=15) was obtained at 20.0 mgL-1 EP constant. Here, the analytical detection limit (S/N) was reached with 4.60 ngL-1 (2.5×10-11 molL-1) EP. The hand-made electrode was implanted into the in-vivo brain core of the animals and was used in chronoamperometric neuro detection. The results obtained are applicable in neuro sensing, physiological control, and other neuroscience fields.
Export Options
About this article
Cite this article as:
Ly Young Suw and Choi woong Dal, Implementation of a Biocircuit Implants for Neurotransmitter Release During Neuro-Stimulation, Current Neurovascular Research 2013; 10 (3) . https://dx.doi.org/10.2174/15672026113109990017
DOI https://dx.doi.org/10.2174/15672026113109990017 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
5-HT<sub>6</sub> Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia
Current Pharmaceutical Design Circulating Aminopeptidase Activities in Men and Women with Essential Hypertension
Current Medicinal Chemistry Alzheimer's disease: Targeting the Cholinergic System
Current Neuropharmacology Obesity and Cardiovascular Physiology: Impact of some Pharmacological Agents
Current Vascular Pharmacology IgA/IgM Responses to Gram-Negative Bacteria are not Associated with Perinatal Depression, but with Physio-somatic Symptoms and Activation of the Tryptophan Catabolite Pathway at the End of Term and Postnatal Anxiety
CNS & Neurological Disorders - Drug Targets The Effects of Psychological Stress on Depression
Current Neuropharmacology Bedtime Hypertension Chronotherapy: Concepts and Patient Outcomes
Current Pharmaceutical Design Medicinal Chemistry Approaches for Glucokinase Activation to Treat Type 2 Diabetes
Current Medicinal Chemistry Adipobiology of Diabetes Mellitus
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Subject Index To Volume 12
Current Pharmaceutical Design Cachexia and Herbal Medicine: Perspective
Current Pharmaceutical Design A Conceptual Framework of Comorbidity for Investigation in the Context of Psychiatric Disturbance
Current Psychiatry Reviews Involvement of Trace Elements in the Pathogenesis of Prion Diseases
Current Pharmaceutical Biotechnology Integrative Neurochemistry and Neurobiology of Social Recognition and Behavior Analyzed with Respect to CD38-Dependent Brain Oxytocin Secretion
Current Topics in Medicinal Chemistry Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk
Current Pharmaceutical Design The Neurophysiology of Hydrogen Sulfide
Inflammation & Allergy - Drug Targets (Discontinued) Seasonal Allergic Rhinitis
Recent Patents on Inflammation & Allergy Drug Discovery Targeting the Fatty Acid Transport Proteins (FATP) to Understand the Mechanisms Linking Fatty Acid Transport to Metabolism
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Some Aspects on Comparative Efficacy Studies with Inhaled Corticosteroids in Asthma
Current Drug Therapy The Ovary Feels Fine when Paracrine and Autocrine Networks Cooperate with Gonadotropins in the Regulation of Folliculogenesis
Current Pharmaceutical Design